Medical Devices & Consumables
Global Subcutaneous Needle-free Injectors Market Research Report 2025
- Dec 02, 25
- ID: 633509
- Pages: 96
- Figures: 90
- Views: 22
Report Scope
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Needle-free Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Needle-free Injectors.
The Subcutaneous Needle-free Injectors market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Subcutaneous Needle-free Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, by Injection Depth and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Needle-free Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Injection Depth and by regions.
By Company
PharmaJet.
Wirthwein Medical GmbH & Co KG
IntegriMedical Pvt Ltd.
CROSSJECT
MIKA MEDICAL CO.
Daicel Corporation
NuGen Medical Devices
Portal Instruments, Inc.
Covestro AG
HealthD
Medical International Technologies (MIT Canada) Inc.
Ferring B.V.
QUINOVARE & TECHiJET.
Beijing QS Medical Technology Co.Ltd
Segment by Type
Gas-Driven
Spring-Driven
Electric-Driven
Manual-Driven
Segment by Injection Depth
Intradermal Injector
Subcutaneous Injector
Intramuscular Injector
Segment by Usage Scenario
Clinical Medical Injector
Household Vaccination Injector
Veterinary Injector
Segment by Application
Hospitals
Clinics
Home Care Settings
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Subcutaneous Needle-free Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Subcutaneous Needle-free Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Needle-free Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Needle-free Injectors.
The Subcutaneous Needle-free Injectors market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Subcutaneous Needle-free Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, by Injection Depth and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Needle-free Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Injection Depth and by regions.
By Company
PharmaJet.
Wirthwein Medical GmbH & Co KG
IntegriMedical Pvt Ltd.
CROSSJECT
MIKA MEDICAL CO.
Daicel Corporation
NuGen Medical Devices
Portal Instruments, Inc.
Covestro AG
HealthD
Medical International Technologies (MIT Canada) Inc.
Ferring B.V.
QUINOVARE & TECHiJET.
Beijing QS Medical Technology Co.Ltd
Segment by Type
Gas-Driven
Spring-Driven
Electric-Driven
Manual-Driven
Segment by Injection Depth
Intradermal Injector
Subcutaneous Injector
Intramuscular Injector
Segment by Usage Scenario
Clinical Medical Injector
Household Vaccination Injector
Veterinary Injector
Segment by Application
Hospitals
Clinics
Home Care Settings
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Subcutaneous Needle-free Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Subcutaneous Needle-free Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Subcutaneous Needle-free Injectors Market Overview
1.1 Product Definition
1.2 Subcutaneous Needle-free Injectors by Type
1.2.1 Global Subcutaneous Needle-free Injectors Market Value Comparison by Type (2024 VS 2031)
1.2.2 Gas-Driven
1.2.3 Spring-Driven
1.2.4 Electric-Driven
1.2.5 Manual-Driven
1.3 Subcutaneous Needle-free Injectors by Injection Depth
1.3.1 Global Subcutaneous Needle-free Injectors Market Value Comparison by Injection Depth: 2024 VS 2031
1.3.2 Intradermal Injector
1.3.3 Subcutaneous Injector
1.3.4 Intramuscular Injector
1.4 Subcutaneous Needle-free Injectors by Usage Scenario
1.4.1 Global Subcutaneous Needle-free Injectors Market Value Comparison by Usage Scenario: 2024 VS 2031
1.4.2 Clinical Medical Injector
1.4.3 Household Vaccination Injector
1.4.4 Veterinary Injector
1.5 Subcutaneous Needle-free Injectors by Application
1.5.1 Global Subcutaneous Needle-free Injectors Market Value by Application (2024 VS 2031)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Home Care Settings
1.5.5 Others
1.6 Global Subcutaneous Needle-free Injectors Market Size Estimates and Forecasts
1.6.1 Global Subcutaneous Needle-free Injectors Revenue 2020-2031
1.6.2 Global Subcutaneous Needle-free Injectors Sales 2020-2031
1.6.3 Global Subcutaneous Needle-free Injectors Market Average Price (2020-2031)
1.7 Assumptions and Limitations
2 Subcutaneous Needle-free Injectors Market Competition by Manufacturers
2.1 Global Subcutaneous Needle-free Injectors Sales Market Share by Manufacturers (2020-2025)
2.2 Global Subcutaneous Needle-free Injectors Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Subcutaneous Needle-free Injectors Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Subcutaneous Needle-free Injectors, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Subcutaneous Needle-free Injectors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Subcutaneous Needle-free Injectors, Product Type & Application
2.7 Global Key Manufacturers of Subcutaneous Needle-free Injectors, Date of Enter into This Industry
2.8 Global Subcutaneous Needle-free Injectors Market Competitive Situation and Trends
2.8.1 Global Subcutaneous Needle-free Injectors Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Subcutaneous Needle-free Injectors Players Market Share by Revenue
2.8.3 Global Subcutaneous Needle-free Injectors Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Subcutaneous Needle-free Injectors Market Scenario by Region
3.1 Global Subcutaneous Needle-free Injectors Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Subcutaneous Needle-free Injectors Sales by Region: 2020-2031
3.2.1 Global Subcutaneous Needle-free Injectors Sales by Region: 2020-2025
3.2.2 Global Subcutaneous Needle-free Injectors Sales by Region: 2026-2031
3.3 Global Subcutaneous Needle-free Injectors Revenue by Region: 2020-2031
3.3.1 Global Subcutaneous Needle-free Injectors Revenue by Region: 2020-2025
3.3.2 Global Subcutaneous Needle-free Injectors Revenue by Region: 2026-2031
3.4 North America Subcutaneous Needle-free Injectors Market Facts & Figures by Country
3.4.1 North America Subcutaneous Needle-free Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Subcutaneous Needle-free Injectors Sales by Country (2020-2031)
3.4.3 North America Subcutaneous Needle-free Injectors Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Subcutaneous Needle-free Injectors Market Facts & Figures by Country
3.5.1 Europe Subcutaneous Needle-free Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Subcutaneous Needle-free Injectors Sales by Country (2020-2031)
3.5.3 Europe Subcutaneous Needle-free Injectors Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Subcutaneous Needle-free Injectors Market Facts & Figures by Region
3.6.1 Asia Pacific Subcutaneous Needle-free Injectors Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Subcutaneous Needle-free Injectors Sales by Region (2020-2031)
3.6.3 Asia Pacific Subcutaneous Needle-free Injectors Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Subcutaneous Needle-free Injectors Market Facts & Figures by Country
3.7.1 Latin America Subcutaneous Needle-free Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Subcutaneous Needle-free Injectors Sales by Country (2020-2031)
3.7.3 Latin America Subcutaneous Needle-free Injectors Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Subcutaneous Needle-free Injectors Market Facts & Figures by Country
3.8.1 Middle East and Africa Subcutaneous Needle-free Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Subcutaneous Needle-free Injectors Sales by Country (2020-2031)
3.8.3 Middle East and Africa Subcutaneous Needle-free Injectors Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Subcutaneous Needle-free Injectors Sales by Type (2020-2031)
4.1.1 Global Subcutaneous Needle-free Injectors Sales by Type (2020-2025)
4.1.2 Global Subcutaneous Needle-free Injectors Sales by Type (2026-2031)
4.1.3 Global Subcutaneous Needle-free Injectors Sales Market Share by Type (2020-2031)
4.2 Global Subcutaneous Needle-free Injectors Revenue by Type (2020-2031)
4.2.1 Global Subcutaneous Needle-free Injectors Revenue by Type (2020-2025)
4.2.2 Global Subcutaneous Needle-free Injectors Revenue by Type (2026-2031)
4.2.3 Global Subcutaneous Needle-free Injectors Revenue Market Share by Type (2020-2031)
4.3 Global Subcutaneous Needle-free Injectors Price by Type (2020-2031)
5 Segment by Application
5.1 Global Subcutaneous Needle-free Injectors Sales by Application (2020-2031)
5.1.1 Global Subcutaneous Needle-free Injectors Sales by Application (2020-2025)
5.1.2 Global Subcutaneous Needle-free Injectors Sales by Application (2026-2031)
5.1.3 Global Subcutaneous Needle-free Injectors Sales Market Share by Application (2020-2031)
5.2 Global Subcutaneous Needle-free Injectors Revenue by Application (2020-2031)
5.2.1 Global Subcutaneous Needle-free Injectors Revenue by Application (2020-2025)
5.2.2 Global Subcutaneous Needle-free Injectors Revenue by Application (2026-2031)
5.2.3 Global Subcutaneous Needle-free Injectors Revenue Market Share by Application (2020-2031)
5.3 Global Subcutaneous Needle-free Injectors Price by Application (2020-2031)
6 Key Companies Profiled
6.1 PharmaJet.
6.1.1 PharmaJet. Company Information
6.1.2 PharmaJet. Description and Business Overview
6.1.3 PharmaJet. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.1.4 PharmaJet. Subcutaneous Needle-free Injectors Product Portfolio
6.1.5 PharmaJet. Recent Developments/Updates
6.2 Wirthwein Medical GmbH & Co KG
6.2.1 Wirthwein Medical GmbH & Co KG Company Information
6.2.2 Wirthwein Medical GmbH & Co KG Description and Business Overview
6.2.3 Wirthwein Medical GmbH & Co KG Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Wirthwein Medical GmbH & Co KG Subcutaneous Needle-free Injectors Product Portfolio
6.2.5 Wirthwein Medical GmbH & Co KG Recent Developments/Updates
6.3 IntegriMedical Pvt Ltd.
6.3.1 IntegriMedical Pvt Ltd. Company Information
6.3.2 IntegriMedical Pvt Ltd. Description and Business Overview
6.3.3 IntegriMedical Pvt Ltd. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.3.4 IntegriMedical Pvt Ltd. Subcutaneous Needle-free Injectors Product Portfolio
6.3.5 IntegriMedical Pvt Ltd. Recent Developments/Updates
6.4 CROSSJECT
6.4.1 CROSSJECT Company Information
6.4.2 CROSSJECT Description and Business Overview
6.4.3 CROSSJECT Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.4.4 CROSSJECT Subcutaneous Needle-free Injectors Product Portfolio
6.4.5 CROSSJECT Recent Developments/Updates
6.5 MIKA MEDICAL CO.
6.5.1 MIKA MEDICAL CO. Company Information
6.5.2 MIKA MEDICAL CO. Description and Business Overview
6.5.3 MIKA MEDICAL CO. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.5.4 MIKA MEDICAL CO. Subcutaneous Needle-free Injectors Product Portfolio
6.5.5 MIKA MEDICAL CO. Recent Developments/Updates
6.6 Daicel Corporation
6.6.1 Daicel Corporation Company Information
6.6.2 Daicel Corporation Description and Business Overview
6.6.3 Daicel Corporation Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Daicel Corporation Subcutaneous Needle-free Injectors Product Portfolio
6.6.5 Daicel Corporation Recent Developments/Updates
6.7 NuGen Medical Devices
6.7.1 NuGen Medical Devices Company Information
6.7.2 NuGen Medical Devices Description and Business Overview
6.7.3 NuGen Medical Devices Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.7.4 NuGen Medical Devices Subcutaneous Needle-free Injectors Product Portfolio
6.7.5 NuGen Medical Devices Recent Developments/Updates
6.8 Portal Instruments, Inc.
6.8.1 Portal Instruments, Inc. Company Information
6.8.2 Portal Instruments, Inc. Description and Business Overview
6.8.3 Portal Instruments, Inc. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Portal Instruments, Inc. Subcutaneous Needle-free Injectors Product Portfolio
6.8.5 Portal Instruments, Inc. Recent Developments/Updates
6.9 Covestro AG
6.9.1 Covestro AG Company Information
6.9.2 Covestro AG Description and Business Overview
6.9.3 Covestro AG Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Covestro AG Subcutaneous Needle-free Injectors Product Portfolio
6.9.5 Covestro AG Recent Developments/Updates
6.10 HealthD
6.10.1 HealthD Company Information
6.10.2 HealthD Description and Business Overview
6.10.3 HealthD Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.10.4 HealthD Subcutaneous Needle-free Injectors Product Portfolio
6.10.5 HealthD Recent Developments/Updates
6.11 Medical International Technologies (MIT Canada) Inc.
6.11.1 Medical International Technologies (MIT Canada) Inc. Company Information
6.11.2 Medical International Technologies (MIT Canada) Inc. Description and Business Overview
6.11.3 Medical International Technologies (MIT Canada) Inc. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Medical International Technologies (MIT Canada) Inc. Subcutaneous Needle-free Injectors Product Portfolio
6.11.5 Medical International Technologies (MIT Canada) Inc. Recent Developments/Updates
6.12 Ferring B.V.
6.12.1 Ferring B.V. Company Information
6.12.2 Ferring B.V. Description and Business Overview
6.12.3 Ferring B.V. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Ferring B.V. Subcutaneous Needle-free Injectors Product Portfolio
6.12.5 Ferring B.V. Recent Developments/Updates
6.13 QUINOVARE & TECHiJET.
6.13.1 QUINOVARE & TECHiJET. Company Information
6.13.2 QUINOVARE & TECHiJET. Description and Business Overview
6.13.3 QUINOVARE & TECHiJET. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.13.4 QUINOVARE & TECHiJET. Subcutaneous Needle-free Injectors Product Portfolio
6.13.5 QUINOVARE & TECHiJET. Recent Developments/Updates
6.14 Beijing QS Medical Technology Co.Ltd
6.14.1 Beijing QS Medical Technology Co.Ltd Company Information
6.14.2 Beijing QS Medical Technology Co.Ltd Description and Business Overview
6.14.3 Beijing QS Medical Technology Co.Ltd Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Beijing QS Medical Technology Co.Ltd Subcutaneous Needle-free Injectors Product Portfolio
6.14.5 Beijing QS Medical Technology Co.Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Subcutaneous Needle-free Injectors Industry Chain Analysis
7.2 Subcutaneous Needle-free Injectors Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Subcutaneous Needle-free Injectors Production Mode & Process Analysis
7.4 Subcutaneous Needle-free Injectors Sales and Marketing
7.4.1 Subcutaneous Needle-free Injectors Sales Channels
7.4.2 Subcutaneous Needle-free Injectors Distributors
7.5 Subcutaneous Needle-free Injectors Customer Analysis
8 Subcutaneous Needle-free Injectors Market Dynamics
8.1 Subcutaneous Needle-free Injectors Industry Trends
8.2 Subcutaneous Needle-free Injectors Market Drivers
8.3 Subcutaneous Needle-free Injectors Market Challenges
8.4 Subcutaneous Needle-free Injectors Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Subcutaneous Needle-free Injectors by Type
1.2.1 Global Subcutaneous Needle-free Injectors Market Value Comparison by Type (2024 VS 2031)
1.2.2 Gas-Driven
1.2.3 Spring-Driven
1.2.4 Electric-Driven
1.2.5 Manual-Driven
1.3 Subcutaneous Needle-free Injectors by Injection Depth
1.3.1 Global Subcutaneous Needle-free Injectors Market Value Comparison by Injection Depth: 2024 VS 2031
1.3.2 Intradermal Injector
1.3.3 Subcutaneous Injector
1.3.4 Intramuscular Injector
1.4 Subcutaneous Needle-free Injectors by Usage Scenario
1.4.1 Global Subcutaneous Needle-free Injectors Market Value Comparison by Usage Scenario: 2024 VS 2031
1.4.2 Clinical Medical Injector
1.4.3 Household Vaccination Injector
1.4.4 Veterinary Injector
1.5 Subcutaneous Needle-free Injectors by Application
1.5.1 Global Subcutaneous Needle-free Injectors Market Value by Application (2024 VS 2031)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Home Care Settings
1.5.5 Others
1.6 Global Subcutaneous Needle-free Injectors Market Size Estimates and Forecasts
1.6.1 Global Subcutaneous Needle-free Injectors Revenue 2020-2031
1.6.2 Global Subcutaneous Needle-free Injectors Sales 2020-2031
1.6.3 Global Subcutaneous Needle-free Injectors Market Average Price (2020-2031)
1.7 Assumptions and Limitations
2 Subcutaneous Needle-free Injectors Market Competition by Manufacturers
2.1 Global Subcutaneous Needle-free Injectors Sales Market Share by Manufacturers (2020-2025)
2.2 Global Subcutaneous Needle-free Injectors Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Subcutaneous Needle-free Injectors Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Subcutaneous Needle-free Injectors, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Subcutaneous Needle-free Injectors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Subcutaneous Needle-free Injectors, Product Type & Application
2.7 Global Key Manufacturers of Subcutaneous Needle-free Injectors, Date of Enter into This Industry
2.8 Global Subcutaneous Needle-free Injectors Market Competitive Situation and Trends
2.8.1 Global Subcutaneous Needle-free Injectors Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Subcutaneous Needle-free Injectors Players Market Share by Revenue
2.8.3 Global Subcutaneous Needle-free Injectors Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Subcutaneous Needle-free Injectors Market Scenario by Region
3.1 Global Subcutaneous Needle-free Injectors Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Subcutaneous Needle-free Injectors Sales by Region: 2020-2031
3.2.1 Global Subcutaneous Needle-free Injectors Sales by Region: 2020-2025
3.2.2 Global Subcutaneous Needle-free Injectors Sales by Region: 2026-2031
3.3 Global Subcutaneous Needle-free Injectors Revenue by Region: 2020-2031
3.3.1 Global Subcutaneous Needle-free Injectors Revenue by Region: 2020-2025
3.3.2 Global Subcutaneous Needle-free Injectors Revenue by Region: 2026-2031
3.4 North America Subcutaneous Needle-free Injectors Market Facts & Figures by Country
3.4.1 North America Subcutaneous Needle-free Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Subcutaneous Needle-free Injectors Sales by Country (2020-2031)
3.4.3 North America Subcutaneous Needle-free Injectors Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Subcutaneous Needle-free Injectors Market Facts & Figures by Country
3.5.1 Europe Subcutaneous Needle-free Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Subcutaneous Needle-free Injectors Sales by Country (2020-2031)
3.5.3 Europe Subcutaneous Needle-free Injectors Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Subcutaneous Needle-free Injectors Market Facts & Figures by Region
3.6.1 Asia Pacific Subcutaneous Needle-free Injectors Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Subcutaneous Needle-free Injectors Sales by Region (2020-2031)
3.6.3 Asia Pacific Subcutaneous Needle-free Injectors Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Subcutaneous Needle-free Injectors Market Facts & Figures by Country
3.7.1 Latin America Subcutaneous Needle-free Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Subcutaneous Needle-free Injectors Sales by Country (2020-2031)
3.7.3 Latin America Subcutaneous Needle-free Injectors Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Subcutaneous Needle-free Injectors Market Facts & Figures by Country
3.8.1 Middle East and Africa Subcutaneous Needle-free Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Subcutaneous Needle-free Injectors Sales by Country (2020-2031)
3.8.3 Middle East and Africa Subcutaneous Needle-free Injectors Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Subcutaneous Needle-free Injectors Sales by Type (2020-2031)
4.1.1 Global Subcutaneous Needle-free Injectors Sales by Type (2020-2025)
4.1.2 Global Subcutaneous Needle-free Injectors Sales by Type (2026-2031)
4.1.3 Global Subcutaneous Needle-free Injectors Sales Market Share by Type (2020-2031)
4.2 Global Subcutaneous Needle-free Injectors Revenue by Type (2020-2031)
4.2.1 Global Subcutaneous Needle-free Injectors Revenue by Type (2020-2025)
4.2.2 Global Subcutaneous Needle-free Injectors Revenue by Type (2026-2031)
4.2.3 Global Subcutaneous Needle-free Injectors Revenue Market Share by Type (2020-2031)
4.3 Global Subcutaneous Needle-free Injectors Price by Type (2020-2031)
5 Segment by Application
5.1 Global Subcutaneous Needle-free Injectors Sales by Application (2020-2031)
5.1.1 Global Subcutaneous Needle-free Injectors Sales by Application (2020-2025)
5.1.2 Global Subcutaneous Needle-free Injectors Sales by Application (2026-2031)
5.1.3 Global Subcutaneous Needle-free Injectors Sales Market Share by Application (2020-2031)
5.2 Global Subcutaneous Needle-free Injectors Revenue by Application (2020-2031)
5.2.1 Global Subcutaneous Needle-free Injectors Revenue by Application (2020-2025)
5.2.2 Global Subcutaneous Needle-free Injectors Revenue by Application (2026-2031)
5.2.3 Global Subcutaneous Needle-free Injectors Revenue Market Share by Application (2020-2031)
5.3 Global Subcutaneous Needle-free Injectors Price by Application (2020-2031)
6 Key Companies Profiled
6.1 PharmaJet.
6.1.1 PharmaJet. Company Information
6.1.2 PharmaJet. Description and Business Overview
6.1.3 PharmaJet. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.1.4 PharmaJet. Subcutaneous Needle-free Injectors Product Portfolio
6.1.5 PharmaJet. Recent Developments/Updates
6.2 Wirthwein Medical GmbH & Co KG
6.2.1 Wirthwein Medical GmbH & Co KG Company Information
6.2.2 Wirthwein Medical GmbH & Co KG Description and Business Overview
6.2.3 Wirthwein Medical GmbH & Co KG Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Wirthwein Medical GmbH & Co KG Subcutaneous Needle-free Injectors Product Portfolio
6.2.5 Wirthwein Medical GmbH & Co KG Recent Developments/Updates
6.3 IntegriMedical Pvt Ltd.
6.3.1 IntegriMedical Pvt Ltd. Company Information
6.3.2 IntegriMedical Pvt Ltd. Description and Business Overview
6.3.3 IntegriMedical Pvt Ltd. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.3.4 IntegriMedical Pvt Ltd. Subcutaneous Needle-free Injectors Product Portfolio
6.3.5 IntegriMedical Pvt Ltd. Recent Developments/Updates
6.4 CROSSJECT
6.4.1 CROSSJECT Company Information
6.4.2 CROSSJECT Description and Business Overview
6.4.3 CROSSJECT Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.4.4 CROSSJECT Subcutaneous Needle-free Injectors Product Portfolio
6.4.5 CROSSJECT Recent Developments/Updates
6.5 MIKA MEDICAL CO.
6.5.1 MIKA MEDICAL CO. Company Information
6.5.2 MIKA MEDICAL CO. Description and Business Overview
6.5.3 MIKA MEDICAL CO. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.5.4 MIKA MEDICAL CO. Subcutaneous Needle-free Injectors Product Portfolio
6.5.5 MIKA MEDICAL CO. Recent Developments/Updates
6.6 Daicel Corporation
6.6.1 Daicel Corporation Company Information
6.6.2 Daicel Corporation Description and Business Overview
6.6.3 Daicel Corporation Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Daicel Corporation Subcutaneous Needle-free Injectors Product Portfolio
6.6.5 Daicel Corporation Recent Developments/Updates
6.7 NuGen Medical Devices
6.7.1 NuGen Medical Devices Company Information
6.7.2 NuGen Medical Devices Description and Business Overview
6.7.3 NuGen Medical Devices Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.7.4 NuGen Medical Devices Subcutaneous Needle-free Injectors Product Portfolio
6.7.5 NuGen Medical Devices Recent Developments/Updates
6.8 Portal Instruments, Inc.
6.8.1 Portal Instruments, Inc. Company Information
6.8.2 Portal Instruments, Inc. Description and Business Overview
6.8.3 Portal Instruments, Inc. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Portal Instruments, Inc. Subcutaneous Needle-free Injectors Product Portfolio
6.8.5 Portal Instruments, Inc. Recent Developments/Updates
6.9 Covestro AG
6.9.1 Covestro AG Company Information
6.9.2 Covestro AG Description and Business Overview
6.9.3 Covestro AG Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Covestro AG Subcutaneous Needle-free Injectors Product Portfolio
6.9.5 Covestro AG Recent Developments/Updates
6.10 HealthD
6.10.1 HealthD Company Information
6.10.2 HealthD Description and Business Overview
6.10.3 HealthD Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.10.4 HealthD Subcutaneous Needle-free Injectors Product Portfolio
6.10.5 HealthD Recent Developments/Updates
6.11 Medical International Technologies (MIT Canada) Inc.
6.11.1 Medical International Technologies (MIT Canada) Inc. Company Information
6.11.2 Medical International Technologies (MIT Canada) Inc. Description and Business Overview
6.11.3 Medical International Technologies (MIT Canada) Inc. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Medical International Technologies (MIT Canada) Inc. Subcutaneous Needle-free Injectors Product Portfolio
6.11.5 Medical International Technologies (MIT Canada) Inc. Recent Developments/Updates
6.12 Ferring B.V.
6.12.1 Ferring B.V. Company Information
6.12.2 Ferring B.V. Description and Business Overview
6.12.3 Ferring B.V. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Ferring B.V. Subcutaneous Needle-free Injectors Product Portfolio
6.12.5 Ferring B.V. Recent Developments/Updates
6.13 QUINOVARE & TECHiJET.
6.13.1 QUINOVARE & TECHiJET. Company Information
6.13.2 QUINOVARE & TECHiJET. Description and Business Overview
6.13.3 QUINOVARE & TECHiJET. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.13.4 QUINOVARE & TECHiJET. Subcutaneous Needle-free Injectors Product Portfolio
6.13.5 QUINOVARE & TECHiJET. Recent Developments/Updates
6.14 Beijing QS Medical Technology Co.Ltd
6.14.1 Beijing QS Medical Technology Co.Ltd Company Information
6.14.2 Beijing QS Medical Technology Co.Ltd Description and Business Overview
6.14.3 Beijing QS Medical Technology Co.Ltd Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Beijing QS Medical Technology Co.Ltd Subcutaneous Needle-free Injectors Product Portfolio
6.14.5 Beijing QS Medical Technology Co.Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Subcutaneous Needle-free Injectors Industry Chain Analysis
7.2 Subcutaneous Needle-free Injectors Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Subcutaneous Needle-free Injectors Production Mode & Process Analysis
7.4 Subcutaneous Needle-free Injectors Sales and Marketing
7.4.1 Subcutaneous Needle-free Injectors Sales Channels
7.4.2 Subcutaneous Needle-free Injectors Distributors
7.5 Subcutaneous Needle-free Injectors Customer Analysis
8 Subcutaneous Needle-free Injectors Market Dynamics
8.1 Subcutaneous Needle-free Injectors Industry Trends
8.2 Subcutaneous Needle-free Injectors Market Drivers
8.3 Subcutaneous Needle-free Injectors Market Challenges
8.4 Subcutaneous Needle-free Injectors Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Subcutaneous Needle-free Injectors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Subcutaneous Needle-free Injectors Market Value by Injection Depth, (US$ Million) & (2024 VS 2031)
Table 3. Global Subcutaneous Needle-free Injectors Market Value by Usage Scenario, (US$ Million) & (2024 VS 2031)
Table 4. Global Subcutaneous Needle-free Injectors Market Value by Application (2024 VS 2031) & (US$ Million)
Table 5. Global Subcutaneous Needle-free Injectors Market Competitive Situation by Manufacturers in 2024
Table 6. Global Subcutaneous Needle-free Injectors Sales (Units) of Key Manufacturers (2020-2025)
Table 7. Global Subcutaneous Needle-free Injectors Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Subcutaneous Needle-free Injectors Revenue (US$ Million) by Manufacturers (2020-2025)
Table 9. Global Subcutaneous Needle-free Injectors Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market Subcutaneous Needle-free Injectors Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 11. Global Key Players of Subcutaneous Needle-free Injectors, Industry Ranking, 2022 VS 2023 VS 2024
Table 12. Global Key Manufacturers of Subcutaneous Needle-free Injectors, Manufacturing Sites & Headquarters
Table 13. Global Key Manufacturers of Subcutaneous Needle-free Injectors, Product Type & Application
Table 14. Global Key Manufacturers of Subcutaneous Needle-free Injectors, Date of Enter into This Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Subcutaneous Needle-free Injectors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Needle-free Injectors as of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Subcutaneous Needle-free Injectors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 19. Global Subcutaneous Needle-free Injectors Sales by Region (2020-2025) & (Units)
Table 20. Global Subcutaneous Needle-free Injectors Sales Market Share by Region (2020-2025)
Table 21. Global Subcutaneous Needle-free Injectors Sales by Region (2026-2031) & (Units)
Table 22. Global Subcutaneous Needle-free Injectors Sales Market Share by Region (2026-2031)
Table 23. Global Subcutaneous Needle-free Injectors Revenue by Region (2020-2025) & (US$ Million)
Table 24. Global Subcutaneous Needle-free Injectors Revenue Market Share by Region (2020-2025)
Table 25. Global Subcutaneous Needle-free Injectors Revenue by Region (2026-2031) & (US$ Million)
Table 26. Global Subcutaneous Needle-free Injectors Revenue Market Share by Region (2026-2031)
Table 27. North America Subcutaneous Needle-free Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. North America Subcutaneous Needle-free Injectors Sales by Country (2020-2025) & (Units)
Table 29. North America Subcutaneous Needle-free Injectors Sales by Country (2026-2031) & (Units)
Table 30. North America Subcutaneous Needle-free Injectors Revenue by Country (2020-2025) & (US$ Million)
Table 31. North America Subcutaneous Needle-free Injectors Revenue by Country (2026-2031) & (US$ Million)
Table 32. Europe Subcutaneous Needle-free Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 33. Europe Subcutaneous Needle-free Injectors Sales by Country (2020-2025) & (Units)
Table 34. Europe Subcutaneous Needle-free Injectors Sales by Country (2026-2031) & (Units)
Table 35. Europe Subcutaneous Needle-free Injectors Revenue by Country (2020-2025) & (US$ Million)
Table 36. Europe Subcutaneous Needle-free Injectors Revenue by Country (2026-2031) & (US$ Million)
Table 37. Asia Pacific Subcutaneous Needle-free Injectors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 38. Asia Pacific Subcutaneous Needle-free Injectors Sales by Region (2020-2025) & (Units)
Table 39. Asia Pacific Subcutaneous Needle-free Injectors Sales by Region (2026-2031) & (Units)
Table 40. Asia Pacific Subcutaneous Needle-free Injectors Revenue by Region (2020-2025) & (US$ Million)
Table 41. Asia Pacific Subcutaneous Needle-free Injectors Revenue by Region (2026-2031) & (US$ Million)
Table 42. Latin America Subcutaneous Needle-free Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Latin America Subcutaneous Needle-free Injectors Sales by Country (2020-2025) & (Units)
Table 44. Latin America Subcutaneous Needle-free Injectors Sales by Country (2026-2031) & (Units)
Table 45. Latin America Subcutaneous Needle-free Injectors Revenue by Country (2020-2025) & (US$ Million)
Table 46. Latin America Subcutaneous Needle-free Injectors Revenue by Country (2026-2031) & (US$ Million)
Table 47. Middle East and Africa Subcutaneous Needle-free Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 48. Middle East and Africa Subcutaneous Needle-free Injectors Sales by Country (2020-2025) & (Units)
Table 49. Middle East and Africa Subcutaneous Needle-free Injectors Sales by Country (2026-2031) & (Units)
Table 50. Middle East and Africa Subcutaneous Needle-free Injectors Revenue by Country (2020-2025) & (US$ Million)
Table 51. Middle East and Africa Subcutaneous Needle-free Injectors Revenue by Country (2026-2031) & (US$ Million)
Table 52. Global Subcutaneous Needle-free Injectors Sales (Units) by Type (2020-2025)
Table 53. Global Subcutaneous Needle-free Injectors Sales (Units) by Type (2026-2031)
Table 54. Global Subcutaneous Needle-free Injectors Sales Market Share by Type (2020-2025)
Table 55. Global Subcutaneous Needle-free Injectors Sales Market Share by Type (2026-2031)
Table 56. Global Subcutaneous Needle-free Injectors Revenue (US$ Million) by Type (2020-2025)
Table 57. Global Subcutaneous Needle-free Injectors Revenue (US$ Million) by Type (2026-2031)
Table 58. Global Subcutaneous Needle-free Injectors Revenue Market Share by Type (2020-2025)
Table 59. Global Subcutaneous Needle-free Injectors Revenue Market Share by Type (2026-2031)
Table 60. Global Subcutaneous Needle-free Injectors Price (US$/Unit) by Type (2020-2025)
Table 61. Global Subcutaneous Needle-free Injectors Price (US$/Unit) by Type (2026-2031)
Table 62. Global Subcutaneous Needle-free Injectors Sales (Units) by Application (2020-2025)
Table 63. Global Subcutaneous Needle-free Injectors Sales (Units) by Application (2026-2031)
Table 64. Global Subcutaneous Needle-free Injectors Sales Market Share by Application (2020-2025)
Table 65. Global Subcutaneous Needle-free Injectors Sales Market Share by Application (2026-2031)
Table 66. Global Subcutaneous Needle-free Injectors Revenue (US$ Million) by Application (2020-2025)
Table 67. Global Subcutaneous Needle-free Injectors Revenue (US$ Million) by Application (2026-2031)
Table 68. Global Subcutaneous Needle-free Injectors Revenue Market Share by Application (2020-2025)
Table 69. Global Subcutaneous Needle-free Injectors Revenue Market Share by Application (2026-2031)
Table 70. Global Subcutaneous Needle-free Injectors Price (US$/Unit) by Application (2020-2025)
Table 71. Global Subcutaneous Needle-free Injectors Price (US$/Unit) by Application (2026-2031)
Table 72. PharmaJet. Company Information
Table 73. PharmaJet. Description and Business Overview
Table 74. PharmaJet. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. PharmaJet. Subcutaneous Needle-free Injectors Product
Table 76. PharmaJet. Recent Developments/Updates
Table 77. Wirthwein Medical GmbH & Co KG Company Information
Table 78. Wirthwein Medical GmbH & Co KG Description and Business Overview
Table 79. Wirthwein Medical GmbH & Co KG Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Wirthwein Medical GmbH & Co KG Subcutaneous Needle-free Injectors Product
Table 81. Wirthwein Medical GmbH & Co KG Recent Developments/Updates
Table 82. IntegriMedical Pvt Ltd. Company Information
Table 83. IntegriMedical Pvt Ltd. Description and Business Overview
Table 84. IntegriMedical Pvt Ltd. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. IntegriMedical Pvt Ltd. Subcutaneous Needle-free Injectors Product
Table 86. IntegriMedical Pvt Ltd. Recent Developments/Updates
Table 87. CROSSJECT Company Information
Table 88. CROSSJECT Description and Business Overview
Table 89. CROSSJECT Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. CROSSJECT Subcutaneous Needle-free Injectors Product
Table 91. CROSSJECT Recent Developments/Updates
Table 92. MIKA MEDICAL CO. Company Information
Table 93. MIKA MEDICAL CO. Description and Business Overview
Table 94. MIKA MEDICAL CO. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. MIKA MEDICAL CO. Subcutaneous Needle-free Injectors Product
Table 96. MIKA MEDICAL CO. Recent Developments/Updates
Table 97. Daicel Corporation Company Information
Table 98. Daicel Corporation Description and Business Overview
Table 99. Daicel Corporation Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Daicel Corporation Subcutaneous Needle-free Injectors Product
Table 101. Daicel Corporation Recent Developments/Updates
Table 102. NuGen Medical Devices Company Information
Table 103. NuGen Medical Devices Description and Business Overview
Table 104. NuGen Medical Devices Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. NuGen Medical Devices Subcutaneous Needle-free Injectors Product
Table 106. NuGen Medical Devices Recent Developments/Updates
Table 107. Portal Instruments, Inc. Company Information
Table 108. Portal Instruments, Inc. Description and Business Overview
Table 109. Portal Instruments, Inc. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Portal Instruments, Inc. Subcutaneous Needle-free Injectors Product
Table 111. Portal Instruments, Inc. Recent Developments/Updates
Table 112. Covestro AG Company Information
Table 113. Covestro AG Description and Business Overview
Table 114. Covestro AG Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Covestro AG Subcutaneous Needle-free Injectors Product
Table 116. Covestro AG Recent Developments/Updates
Table 117. HealthD Company Information
Table 118. HealthD Description and Business Overview
Table 119. HealthD Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. HealthD Subcutaneous Needle-free Injectors Product
Table 121. HealthD Recent Developments/Updates
Table 122. Medical International Technologies (MIT Canada) Inc. Company Information
Table 123. Medical International Technologies (MIT Canada) Inc. Description and Business Overview
Table 124. Medical International Technologies (MIT Canada) Inc. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Medical International Technologies (MIT Canada) Inc. Subcutaneous Needle-free Injectors Product
Table 126. Medical International Technologies (MIT Canada) Inc. Recent Developments/Updates
Table 127. Ferring B.V. Company Information
Table 128. Ferring B.V. Description and Business Overview
Table 129. Ferring B.V. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Ferring B.V. Subcutaneous Needle-free Injectors Product
Table 131. Ferring B.V. Recent Developments/Updates
Table 132. QUINOVARE & TECHiJET. Company Information
Table 133. QUINOVARE & TECHiJET. Description and Business Overview
Table 134. QUINOVARE & TECHiJET. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. QUINOVARE & TECHiJET. Subcutaneous Needle-free Injectors Product
Table 136. QUINOVARE & TECHiJET. Recent Developments/Updates
Table 137. Beijing QS Medical Technology Co.Ltd Company Information
Table 138. Beijing QS Medical Technology Co.Ltd Description and Business Overview
Table 139. Beijing QS Medical Technology Co.Ltd Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 140. Beijing QS Medical Technology Co.Ltd Subcutaneous Needle-free Injectors Product
Table 141. Beijing QS Medical Technology Co.Ltd Recent Developments/Updates
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Subcutaneous Needle-free Injectors Distributors List
Table 145. Subcutaneous Needle-free Injectors Customers List
Table 146. Subcutaneous Needle-free Injectors Market Trends
Table 147. Subcutaneous Needle-free Injectors Market Drivers
Table 148. Subcutaneous Needle-free Injectors Market Challenges
Table 149. Subcutaneous Needle-free Injectors Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
Table 153. Authors List of This Report
List of Figures
Figure 1. Product Picture of Subcutaneous Needle-free Injectors
Figure 2. Global Subcutaneous Needle-free Injectors Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Subcutaneous Needle-free Injectors Market Share by Type: 2024 & 2031
Figure 4. Gas-Driven Product Picture
Figure 5. Spring-Driven Product Picture
Figure 6. Electric-Driven Product Picture
Figure 7. Manual-Driven Product Picture
Figure 8. Global Subcutaneous Needle-free Injectors Market Value by Injection Depth, (US$ Million) & (2020-2031)
Figure 9. Global Subcutaneous Needle-free Injectors Market Share by Injection Depth: 2024 VS 2031
Figure 10. Intradermal Injector Product Picture
Figure 11. Subcutaneous Injector Product Picture
Figure 12. Intramuscular Injector Product Picture
Figure 13. Global Subcutaneous Needle-free Injectors Market Value by Usage Scenario, (US$ Million) & (2020-2031)
Figure 14. Global Subcutaneous Needle-free Injectors Market Share by Usage Scenario: 2024 VS 2031
Figure 15. Clinical Medical Injector Product Picture
Figure 16. Household Vaccination Injector Product Picture
Figure 17. Veterinary Injector Product Picture
Figure 18. Global Subcutaneous Needle-free Injectors Market Value by Application (2020-2031) & (US$ Million)
Figure 19. Global Subcutaneous Needle-free Injectors Market Share by Application: 2024 & 2031
Figure 20. Hospitals
Figure 21. Clinics
Figure 22. Home Care Settings
Figure 23. Others
Figure 24. Global Subcutaneous Needle-free Injectors Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 25. Global Subcutaneous Needle-free Injectors Market Size (2020-2031) & (US$ Million)
Figure 26. Global Subcutaneous Needle-free Injectors Sales (2020-2031) & (Units)
Figure 27. Global Subcutaneous Needle-free Injectors Average Price (US$/Unit) & (2020-2031)
Figure 28. Subcutaneous Needle-free Injectors Report Years Considered
Figure 29. Subcutaneous Needle-free Injectors Sales Share by Manufacturers in 2024
Figure 30. Global Subcutaneous Needle-free Injectors Revenue Share by Manufacturers in 2024
Figure 31. Global 5 and 10 Largest Subcutaneous Needle-free Injectors Players: Market Share by Revenue in Subcutaneous Needle-free Injectors in 2024
Figure 32. Subcutaneous Needle-free Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 33. Global Subcutaneous Needle-free Injectors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 34. North America Subcutaneous Needle-free Injectors Sales Market Share by Country (2020-2031)
Figure 35. North America Subcutaneous Needle-free Injectors Revenue Market Share by Country (2020-2031)
Figure 36. United States Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Canada Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Europe Subcutaneous Needle-free Injectors Sales Market Share by Country (2020-2031)
Figure 39. Europe Subcutaneous Needle-free Injectors Revenue Market Share by Country (2020-2031)
Figure 40. Germany Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. France Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. U.K. Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Italy Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Russia Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Asia Pacific Subcutaneous Needle-free Injectors Sales Market Share by Region (2020-2031)
Figure 46. Asia Pacific Subcutaneous Needle-free Injectors Revenue Market Share by Region (2020-2031)
Figure 47. China Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Japan Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. South Korea Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. India Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Australia Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. China Taiwan Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Southeast Asia Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Latin America Subcutaneous Needle-free Injectors Sales Market Share by Country (2020-2031)
Figure 55. Latin America Subcutaneous Needle-free Injectors Revenue Market Share by Country (2020-2031)
Figure 56. Mexico Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Brazil Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Argentina Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Colombia Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. Middle East and Africa Subcutaneous Needle-free Injectors Sales Market Share by Country (2020-2031)
Figure 61. Middle East and Africa Subcutaneous Needle-free Injectors Revenue Market Share by Country (2020-2031)
Figure 62. Turkey Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 63. Saudi Arabia Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 64. UAE Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 65. Global Sales Market Share of Subcutaneous Needle-free Injectors by Type (2020-2031)
Figure 66. Global Revenue Market Share of Subcutaneous Needle-free Injectors by Type (2020-2031)
Figure 67. Global Subcutaneous Needle-free Injectors Price (US$/Unit) by Type (2020-2031)
Figure 68. Global Sales Market Share of Subcutaneous Needle-free Injectors by Application (2020-2031)
Figure 69. Global Revenue Market Share of Subcutaneous Needle-free Injectors by Application (2020-2031)
Figure 70. Global Subcutaneous Needle-free Injectors Price (US$/Unit) by Application (2020-2031)
Figure 71. Subcutaneous Needle-free Injectors Value Chain
Figure 72. Channels of Distribution (Direct Vs Distribution)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Table 1. Global Subcutaneous Needle-free Injectors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Subcutaneous Needle-free Injectors Market Value by Injection Depth, (US$ Million) & (2024 VS 2031)
Table 3. Global Subcutaneous Needle-free Injectors Market Value by Usage Scenario, (US$ Million) & (2024 VS 2031)
Table 4. Global Subcutaneous Needle-free Injectors Market Value by Application (2024 VS 2031) & (US$ Million)
Table 5. Global Subcutaneous Needle-free Injectors Market Competitive Situation by Manufacturers in 2024
Table 6. Global Subcutaneous Needle-free Injectors Sales (Units) of Key Manufacturers (2020-2025)
Table 7. Global Subcutaneous Needle-free Injectors Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Subcutaneous Needle-free Injectors Revenue (US$ Million) by Manufacturers (2020-2025)
Table 9. Global Subcutaneous Needle-free Injectors Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market Subcutaneous Needle-free Injectors Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 11. Global Key Players of Subcutaneous Needle-free Injectors, Industry Ranking, 2022 VS 2023 VS 2024
Table 12. Global Key Manufacturers of Subcutaneous Needle-free Injectors, Manufacturing Sites & Headquarters
Table 13. Global Key Manufacturers of Subcutaneous Needle-free Injectors, Product Type & Application
Table 14. Global Key Manufacturers of Subcutaneous Needle-free Injectors, Date of Enter into This Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Subcutaneous Needle-free Injectors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Needle-free Injectors as of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Subcutaneous Needle-free Injectors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 19. Global Subcutaneous Needle-free Injectors Sales by Region (2020-2025) & (Units)
Table 20. Global Subcutaneous Needle-free Injectors Sales Market Share by Region (2020-2025)
Table 21. Global Subcutaneous Needle-free Injectors Sales by Region (2026-2031) & (Units)
Table 22. Global Subcutaneous Needle-free Injectors Sales Market Share by Region (2026-2031)
Table 23. Global Subcutaneous Needle-free Injectors Revenue by Region (2020-2025) & (US$ Million)
Table 24. Global Subcutaneous Needle-free Injectors Revenue Market Share by Region (2020-2025)
Table 25. Global Subcutaneous Needle-free Injectors Revenue by Region (2026-2031) & (US$ Million)
Table 26. Global Subcutaneous Needle-free Injectors Revenue Market Share by Region (2026-2031)
Table 27. North America Subcutaneous Needle-free Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. North America Subcutaneous Needle-free Injectors Sales by Country (2020-2025) & (Units)
Table 29. North America Subcutaneous Needle-free Injectors Sales by Country (2026-2031) & (Units)
Table 30. North America Subcutaneous Needle-free Injectors Revenue by Country (2020-2025) & (US$ Million)
Table 31. North America Subcutaneous Needle-free Injectors Revenue by Country (2026-2031) & (US$ Million)
Table 32. Europe Subcutaneous Needle-free Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 33. Europe Subcutaneous Needle-free Injectors Sales by Country (2020-2025) & (Units)
Table 34. Europe Subcutaneous Needle-free Injectors Sales by Country (2026-2031) & (Units)
Table 35. Europe Subcutaneous Needle-free Injectors Revenue by Country (2020-2025) & (US$ Million)
Table 36. Europe Subcutaneous Needle-free Injectors Revenue by Country (2026-2031) & (US$ Million)
Table 37. Asia Pacific Subcutaneous Needle-free Injectors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 38. Asia Pacific Subcutaneous Needle-free Injectors Sales by Region (2020-2025) & (Units)
Table 39. Asia Pacific Subcutaneous Needle-free Injectors Sales by Region (2026-2031) & (Units)
Table 40. Asia Pacific Subcutaneous Needle-free Injectors Revenue by Region (2020-2025) & (US$ Million)
Table 41. Asia Pacific Subcutaneous Needle-free Injectors Revenue by Region (2026-2031) & (US$ Million)
Table 42. Latin America Subcutaneous Needle-free Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Latin America Subcutaneous Needle-free Injectors Sales by Country (2020-2025) & (Units)
Table 44. Latin America Subcutaneous Needle-free Injectors Sales by Country (2026-2031) & (Units)
Table 45. Latin America Subcutaneous Needle-free Injectors Revenue by Country (2020-2025) & (US$ Million)
Table 46. Latin America Subcutaneous Needle-free Injectors Revenue by Country (2026-2031) & (US$ Million)
Table 47. Middle East and Africa Subcutaneous Needle-free Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 48. Middle East and Africa Subcutaneous Needle-free Injectors Sales by Country (2020-2025) & (Units)
Table 49. Middle East and Africa Subcutaneous Needle-free Injectors Sales by Country (2026-2031) & (Units)
Table 50. Middle East and Africa Subcutaneous Needle-free Injectors Revenue by Country (2020-2025) & (US$ Million)
Table 51. Middle East and Africa Subcutaneous Needle-free Injectors Revenue by Country (2026-2031) & (US$ Million)
Table 52. Global Subcutaneous Needle-free Injectors Sales (Units) by Type (2020-2025)
Table 53. Global Subcutaneous Needle-free Injectors Sales (Units) by Type (2026-2031)
Table 54. Global Subcutaneous Needle-free Injectors Sales Market Share by Type (2020-2025)
Table 55. Global Subcutaneous Needle-free Injectors Sales Market Share by Type (2026-2031)
Table 56. Global Subcutaneous Needle-free Injectors Revenue (US$ Million) by Type (2020-2025)
Table 57. Global Subcutaneous Needle-free Injectors Revenue (US$ Million) by Type (2026-2031)
Table 58. Global Subcutaneous Needle-free Injectors Revenue Market Share by Type (2020-2025)
Table 59. Global Subcutaneous Needle-free Injectors Revenue Market Share by Type (2026-2031)
Table 60. Global Subcutaneous Needle-free Injectors Price (US$/Unit) by Type (2020-2025)
Table 61. Global Subcutaneous Needle-free Injectors Price (US$/Unit) by Type (2026-2031)
Table 62. Global Subcutaneous Needle-free Injectors Sales (Units) by Application (2020-2025)
Table 63. Global Subcutaneous Needle-free Injectors Sales (Units) by Application (2026-2031)
Table 64. Global Subcutaneous Needle-free Injectors Sales Market Share by Application (2020-2025)
Table 65. Global Subcutaneous Needle-free Injectors Sales Market Share by Application (2026-2031)
Table 66. Global Subcutaneous Needle-free Injectors Revenue (US$ Million) by Application (2020-2025)
Table 67. Global Subcutaneous Needle-free Injectors Revenue (US$ Million) by Application (2026-2031)
Table 68. Global Subcutaneous Needle-free Injectors Revenue Market Share by Application (2020-2025)
Table 69. Global Subcutaneous Needle-free Injectors Revenue Market Share by Application (2026-2031)
Table 70. Global Subcutaneous Needle-free Injectors Price (US$/Unit) by Application (2020-2025)
Table 71. Global Subcutaneous Needle-free Injectors Price (US$/Unit) by Application (2026-2031)
Table 72. PharmaJet. Company Information
Table 73. PharmaJet. Description and Business Overview
Table 74. PharmaJet. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. PharmaJet. Subcutaneous Needle-free Injectors Product
Table 76. PharmaJet. Recent Developments/Updates
Table 77. Wirthwein Medical GmbH & Co KG Company Information
Table 78. Wirthwein Medical GmbH & Co KG Description and Business Overview
Table 79. Wirthwein Medical GmbH & Co KG Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Wirthwein Medical GmbH & Co KG Subcutaneous Needle-free Injectors Product
Table 81. Wirthwein Medical GmbH & Co KG Recent Developments/Updates
Table 82. IntegriMedical Pvt Ltd. Company Information
Table 83. IntegriMedical Pvt Ltd. Description and Business Overview
Table 84. IntegriMedical Pvt Ltd. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. IntegriMedical Pvt Ltd. Subcutaneous Needle-free Injectors Product
Table 86. IntegriMedical Pvt Ltd. Recent Developments/Updates
Table 87. CROSSJECT Company Information
Table 88. CROSSJECT Description and Business Overview
Table 89. CROSSJECT Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. CROSSJECT Subcutaneous Needle-free Injectors Product
Table 91. CROSSJECT Recent Developments/Updates
Table 92. MIKA MEDICAL CO. Company Information
Table 93. MIKA MEDICAL CO. Description and Business Overview
Table 94. MIKA MEDICAL CO. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. MIKA MEDICAL CO. Subcutaneous Needle-free Injectors Product
Table 96. MIKA MEDICAL CO. Recent Developments/Updates
Table 97. Daicel Corporation Company Information
Table 98. Daicel Corporation Description and Business Overview
Table 99. Daicel Corporation Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Daicel Corporation Subcutaneous Needle-free Injectors Product
Table 101. Daicel Corporation Recent Developments/Updates
Table 102. NuGen Medical Devices Company Information
Table 103. NuGen Medical Devices Description and Business Overview
Table 104. NuGen Medical Devices Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. NuGen Medical Devices Subcutaneous Needle-free Injectors Product
Table 106. NuGen Medical Devices Recent Developments/Updates
Table 107. Portal Instruments, Inc. Company Information
Table 108. Portal Instruments, Inc. Description and Business Overview
Table 109. Portal Instruments, Inc. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Portal Instruments, Inc. Subcutaneous Needle-free Injectors Product
Table 111. Portal Instruments, Inc. Recent Developments/Updates
Table 112. Covestro AG Company Information
Table 113. Covestro AG Description and Business Overview
Table 114. Covestro AG Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Covestro AG Subcutaneous Needle-free Injectors Product
Table 116. Covestro AG Recent Developments/Updates
Table 117. HealthD Company Information
Table 118. HealthD Description and Business Overview
Table 119. HealthD Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. HealthD Subcutaneous Needle-free Injectors Product
Table 121. HealthD Recent Developments/Updates
Table 122. Medical International Technologies (MIT Canada) Inc. Company Information
Table 123. Medical International Technologies (MIT Canada) Inc. Description and Business Overview
Table 124. Medical International Technologies (MIT Canada) Inc. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Medical International Technologies (MIT Canada) Inc. Subcutaneous Needle-free Injectors Product
Table 126. Medical International Technologies (MIT Canada) Inc. Recent Developments/Updates
Table 127. Ferring B.V. Company Information
Table 128. Ferring B.V. Description and Business Overview
Table 129. Ferring B.V. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Ferring B.V. Subcutaneous Needle-free Injectors Product
Table 131. Ferring B.V. Recent Developments/Updates
Table 132. QUINOVARE & TECHiJET. Company Information
Table 133. QUINOVARE & TECHiJET. Description and Business Overview
Table 134. QUINOVARE & TECHiJET. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. QUINOVARE & TECHiJET. Subcutaneous Needle-free Injectors Product
Table 136. QUINOVARE & TECHiJET. Recent Developments/Updates
Table 137. Beijing QS Medical Technology Co.Ltd Company Information
Table 138. Beijing QS Medical Technology Co.Ltd Description and Business Overview
Table 139. Beijing QS Medical Technology Co.Ltd Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 140. Beijing QS Medical Technology Co.Ltd Subcutaneous Needle-free Injectors Product
Table 141. Beijing QS Medical Technology Co.Ltd Recent Developments/Updates
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Subcutaneous Needle-free Injectors Distributors List
Table 145. Subcutaneous Needle-free Injectors Customers List
Table 146. Subcutaneous Needle-free Injectors Market Trends
Table 147. Subcutaneous Needle-free Injectors Market Drivers
Table 148. Subcutaneous Needle-free Injectors Market Challenges
Table 149. Subcutaneous Needle-free Injectors Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
Table 153. Authors List of This Report
List of Figures
Figure 1. Product Picture of Subcutaneous Needle-free Injectors
Figure 2. Global Subcutaneous Needle-free Injectors Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Subcutaneous Needle-free Injectors Market Share by Type: 2024 & 2031
Figure 4. Gas-Driven Product Picture
Figure 5. Spring-Driven Product Picture
Figure 6. Electric-Driven Product Picture
Figure 7. Manual-Driven Product Picture
Figure 8. Global Subcutaneous Needle-free Injectors Market Value by Injection Depth, (US$ Million) & (2020-2031)
Figure 9. Global Subcutaneous Needle-free Injectors Market Share by Injection Depth: 2024 VS 2031
Figure 10. Intradermal Injector Product Picture
Figure 11. Subcutaneous Injector Product Picture
Figure 12. Intramuscular Injector Product Picture
Figure 13. Global Subcutaneous Needle-free Injectors Market Value by Usage Scenario, (US$ Million) & (2020-2031)
Figure 14. Global Subcutaneous Needle-free Injectors Market Share by Usage Scenario: 2024 VS 2031
Figure 15. Clinical Medical Injector Product Picture
Figure 16. Household Vaccination Injector Product Picture
Figure 17. Veterinary Injector Product Picture
Figure 18. Global Subcutaneous Needle-free Injectors Market Value by Application (2020-2031) & (US$ Million)
Figure 19. Global Subcutaneous Needle-free Injectors Market Share by Application: 2024 & 2031
Figure 20. Hospitals
Figure 21. Clinics
Figure 22. Home Care Settings
Figure 23. Others
Figure 24. Global Subcutaneous Needle-free Injectors Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 25. Global Subcutaneous Needle-free Injectors Market Size (2020-2031) & (US$ Million)
Figure 26. Global Subcutaneous Needle-free Injectors Sales (2020-2031) & (Units)
Figure 27. Global Subcutaneous Needle-free Injectors Average Price (US$/Unit) & (2020-2031)
Figure 28. Subcutaneous Needle-free Injectors Report Years Considered
Figure 29. Subcutaneous Needle-free Injectors Sales Share by Manufacturers in 2024
Figure 30. Global Subcutaneous Needle-free Injectors Revenue Share by Manufacturers in 2024
Figure 31. Global 5 and 10 Largest Subcutaneous Needle-free Injectors Players: Market Share by Revenue in Subcutaneous Needle-free Injectors in 2024
Figure 32. Subcutaneous Needle-free Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 33. Global Subcutaneous Needle-free Injectors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 34. North America Subcutaneous Needle-free Injectors Sales Market Share by Country (2020-2031)
Figure 35. North America Subcutaneous Needle-free Injectors Revenue Market Share by Country (2020-2031)
Figure 36. United States Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Canada Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Europe Subcutaneous Needle-free Injectors Sales Market Share by Country (2020-2031)
Figure 39. Europe Subcutaneous Needle-free Injectors Revenue Market Share by Country (2020-2031)
Figure 40. Germany Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. France Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. U.K. Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Italy Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Russia Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Asia Pacific Subcutaneous Needle-free Injectors Sales Market Share by Region (2020-2031)
Figure 46. Asia Pacific Subcutaneous Needle-free Injectors Revenue Market Share by Region (2020-2031)
Figure 47. China Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Japan Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. South Korea Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. India Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Australia Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. China Taiwan Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Southeast Asia Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Latin America Subcutaneous Needle-free Injectors Sales Market Share by Country (2020-2031)
Figure 55. Latin America Subcutaneous Needle-free Injectors Revenue Market Share by Country (2020-2031)
Figure 56. Mexico Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Brazil Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Argentina Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Colombia Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. Middle East and Africa Subcutaneous Needle-free Injectors Sales Market Share by Country (2020-2031)
Figure 61. Middle East and Africa Subcutaneous Needle-free Injectors Revenue Market Share by Country (2020-2031)
Figure 62. Turkey Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 63. Saudi Arabia Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 64. UAE Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 65. Global Sales Market Share of Subcutaneous Needle-free Injectors by Type (2020-2031)
Figure 66. Global Revenue Market Share of Subcutaneous Needle-free Injectors by Type (2020-2031)
Figure 67. Global Subcutaneous Needle-free Injectors Price (US$/Unit) by Type (2020-2031)
Figure 68. Global Sales Market Share of Subcutaneous Needle-free Injectors by Application (2020-2031)
Figure 69. Global Revenue Market Share of Subcutaneous Needle-free Injectors by Application (2020-2031)
Figure 70. Global Subcutaneous Needle-free Injectors Price (US$/Unit) by Application (2020-2031)
Figure 71. Subcutaneous Needle-free Injectors Value Chain
Figure 72. Channels of Distribution (Direct Vs Distribution)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232